External-stimuli responsive systems for cancer theranostic

Asian Journal of Pharmaceutical Sciences

Volumn 11, Issue 5, 2016, Pages 585-595

  Yao, Jianhui ^a   Feng, Jingxian ^a   Chen, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Light; Magnetic field; Nanotechnology; Stimuli responsive; Theranostics; Ultrasound

Indexed keywords

NANOMATERIAL;

DRUG DELIVERY SYSTEM; EXTERNAL STIMULUS; HUMAN; HYPERTHERMIA; LIGHT; MAGNETIC FIELD; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; REVIEW; STIMULUS; THERANOSTIC NANOMEDICINE; ULTRASOUND;

EID: 84984799769     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2016.06.001     Document Type: Review

References (92)

1. [1] Hu, Q., Katti, P.S., Gu, Z., Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale 6 (2014), 12273–12286.
2. [2] Khadka, P., Ro, J., Kim, H., et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9 (2014), 304–316.
3. [3] Toh, M.R., Chiu, G.N.C., Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing. Asian J Pharm Sci 8 (2013), 88–95.
4. [4] Fleige, E., Quadir, M.A., Haag, R., Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64 (2012), 866–884.
5. [5] Liu, Y., Wang, W., Yang, J., et al. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharm Sci 8 (2013), 159–167.
6. [6] Lehner, R., Wang, X., Wolf, M., et al. Designing switchable nanosystems for medical application. J Control Release 161 (2012), 307–316.
7. [7] Chen, Q., Ke, H., Dai, Z., et al. Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials 73 (2015), 214–230.
8. [8] Dougherty, T.J., Gomer, C.J., Henderson, B.W., et al. Photodynamic therapy. J Natl Cancer Inst 90 (1998), 889–905.
9. [9] Master, A., Livingston, M., Sen Gupta, A., Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 168 (2013), 88–102.
10. [10] Lovell, J.F., Jin, C.S., Huynh, E., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 10 (2011), 324–332.
11. [11] Jin, C.S., Cui, L., Wang, F., et al. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv Healthc Mater 3 (2014), 1240–1249.
12. [12] Kou, L., Sun, J., Zhai, Y., et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci 8 (2013), 1–10.
13. [13] Kim, J., Santos, O.A., Park, J.H., Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J Control Release 191 (2014), 98–104.
14. [14] Shapira, A., Livney, Y.D., Broxterman, H.J., et al. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 14 (2011), 150–163.
15. [15] Wong, B.S., Yoong, S.L., Jagusiak, A., et al. Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65 (2013), 1964–2015.
16. [16] Jiang, D., Gao, X., Kang, T., et al. Actively targeting d-alpha-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Nanoscale 8 (2016), 3100–3118.
17. [17] Reinhold, H.S., Endrich, B., Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 2 (1986), 111–137.
18. [18] Kim, H., Chung, K., Lee, S., et al. Near-infrared light-responsive nanomaterials for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8 (2016), 1022–1098.
19. [19] Park, J.H., Von Maltzahn, G., Ong, L.L., et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater 22 (2010), 880–885.
20. [20] Ji, H., Sun, H., Qu, X., Antibacterial applications of graphene-based nanomaterials: recent achievements and challenges. Adv Drug Deliv Rev 25 (2016), 857–861.
21. [21] Gao, S., Zhang, L., Wang, G., et al. Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy. Biomaterials 79 (2015), 28–54.
22. [22] El-Sayed, S.L., Shape, A.M., and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem 19 (2000), 409–453.
23. [23] Zha, Z., Yue, X., Ren, Q., et al. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater 25 (2013), 777–782.
24. [24] Tian, Q., Tang, M., Sun, Y., et al. Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells. AIDS Care 23 (2011), 3542–3547.
25. [25] Meng, Z., Wei, F., Wang, R., et al. Tumor therapy: NIR-laser-switched in vivo smart nanocapsules for synergic photothermal and chemotherapy of tumors. Adv Mater 28:2 (2016), 245–253.
26. [26] Pang, B., Zhao, Y., Luehmann, H., et al. (64)Cu-Doped PdCu@Au Tripods: a multifunctional nanomaterial for positron emission tomography and image-guided photothermal cancer treatment. Angew Chem Int Ed Engl 1 (1962), 246–264.
27. [27] Jhaveri, A., Deshpande, P., Torchilin, V., Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release 190 (2014), 352–370.
28. [28] Wang, C., Tao, H., Cheng, L., et al. Near-infrared light induced invivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 32 (2011), 6145–6154.
29. [29] Caixia, Y., Chunlei, Z., Gabriel, A., et al. Near-Infrared light triggered ROS-activated theranostic platform based on Ce6-CPT-UCNPs for simultaneous fluorescence imaging and chemo-photodynamic combined therapy. Theranostics 6 (2016), 456–469.
30. [30] Duarte, A., Pu, K.Y., Liu, B., et al. Recent advances in conjugated polyelectrolytes for emerging optoelectronic applications. Chem Mater 23 (2010), 501–515.
31. [31] Zhu, C., Yang, Q., Lv, F., et al. Conjugated polymer-coated bacteria for multimodal intracellular and extracellular anticancer activity. Adv Mater 25 (2013), 1203–1208.
32. [32] Yuan, Y., Liu, J., Liu, B., Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source. Angew Chem Int Ed Engl 53 (2014), 7163–7168.
33. [33] Ryu, J.H., Lee, S., Son, S., et al. Theranostic nanoparticles for future personalized medicine. J Control Release 190 (2014), 477–484.
34. [34] Cutler, C.S., Hennkens, H.M., Sisay, N., et al. Radiometals for combined imaging and therapy. Chem Rev 113 (2012), 858–883.
35. [35] Sanjiv Sam, G., Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2 (2002), 683–693.
36. [36] Sun, X., Huang, X., Yan, X., et al. Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy. ACS Nano 8 (2014), 8438–8446.
37. [37] So Jin, L., Kyeongsoon, P., Yu-Kyoung, O., et al. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 30 (2009), 2929–2939.
38. [38] Niamien, K.Y., Robert, G., Eric, A., State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 66 (2002), 89–106.
39. [39] Akiyoshi, K., Deguchi, S., Tajima, H., et al. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules 30 (1997), 857–861.
40. [40] Koo, H., Lee, H., Lee, S., et al. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun (Camb) 46 (2010), 5668–5670.
41. [41] Sheng, Z., Hu, D., Xue, M., et al. Indocyanine green nanoparticles for theranostic applications. Nano Micro Lett 5 (2013), 145–150.
42. [42] Sheng, Z., Hu, D., Zheng, M., et al. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy. ACS Nano 8 (2014), 12310–12322.
43. [43] Sun, C., Lee, J.S., Zhang, M., Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60 (2008), 1252–1265.
44. [44] Karimi, M., Ghasemi, A., Sahandi, Z.P., et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. J Control Release 219 (2016), 355–368.
45. [45] Dongwon, Y., Jae-Hyun, L., Tae-Hyun, S., et al. Theranostic magnetic nanoparticles. Acc Chem Res 44 (2011), 863–874.
46. [46] Chenjie, X., Shouheng, S., New forms of superparamagnetic nanoparticles for biomedical applications. Adv Drug Deliv Rev 65 (2013), 732–743.
47. [47] Shubayev, V.I., Pisanic, T.R., Jin, S., Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61 (2009), 467–477.
48. [48] Ajay Kumar, G., Naregalkar, R.R., Vikas Deep, V., et al. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (Lond) 2 (2007), 23–39.
49. [49] Hua, M.Y., Liu, H.L., Yang, H.W., et al. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas. Biomaterials 32 (2011), 516–527.
50. [50] Choi, S.H., Lee, J.H., Choi, S.M., et al. Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition. Langmuir 22 (2006), 1758–1762.
51. [51] Liu, T.Y., Liu, K.H., Liu, D.M., et al. Temperature-sensitive nanocapsules for controlled drug release caused by magnetically triggered structural disruption. Adv Funct Mater 19 (2009), 616–623.
52. [52] Fortin, J.P., Wilhelm, C., Servais, J., et al. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 129 (2007), 2628–2635.
53. [53] Pan, Y., Petersen, N., Winklhofer, M., et al. Rock magnetic properties of uncultured magnetotactic bacteria. Earth Planet Sci Lett 237 (2005), 311–325.
54. [54] Okamura, Y., Takeyama, H., Matsunaga, T., Two-dimensional analysis of proteins specific to the bacterial magnetic particle membrane from Magnetospirillum sp. AMB-1. Appl Biochem Biotechnol, 84–86, 2000, 441.
55. [55] Lefevre, C.T., Abreu, F., Lins, U., et al. A bacterial backbone: magnetosomes in magnetotactic bacteria. Metal nanoparticles in microbiology, 2011, Springer, Berlin, Heidelberg, 75–102.
56. [56] Dutz, S., Clement, J.H., Eberbeck, D., et al. Ferrofluids of magnetic multicore nanoparticles for biomedical applications. J Magn Magn Mater 321 (2009), 1501–1504.
57. [57] Guo, L., Bacterial magnetic nanoparticles as drug carriers. J Mater Chem 18 (2008), 5993–5997.
58. [58] Alphandéry, E., Faure, S., Seksek, O., et al. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano 5 (2011), 6279–6296.
59. [59] Choi, J., Shin, J., Lee, J., et al. Magnetic response of mitochondria-targeted cancer cells with bacterial magnetic nanoparticles. Chem Commun (Camb) 48 (2012), 7474–7476.
60. [60] Tang, Y.S., Wang, D., Zhou, C., et al. Bacterial magnetic particles as a novel and efficient gene vaccine delivery system. Gene Ther 19 (2012), 1187–1195.
61. [61] Soukup, D., Moise, S., Céspedes, E., et al. In situ measurement of magnetization relaxation of internalized nanoparticles in live cells. ACS Nano 9 (2015), 231–240.
62. [62] Shi, D., Sadat, M.E., Dunn, A.W., et al. Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications. Nanoscale 7 (2015), 8209–8232.
63. [63] Di Corato, R., Bealle, G., Kolosnjaj-Tabi, J., et al. Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes. ACS Nano 9 (2015), 2904–2916.
64. [64] Szakács, G., Paterson, J.K., Ludwig, J.A., et al. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5 (2006), 219–234.
65. [65] Pan, Y., Du, X., Zhao, F., et al. Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev 41 (2012), 2912–2942.
66. [66] Yoo, D., Jeong, H., Noh, S.H., et al. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angew Chem Int Ed Engl 52 (2013), 13047–13051.
67. [67] Creixell, M., Bohorquez, A.C., Torres-Lugo, M., et al. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 5 (2011), 7124–7129.
68. [68] Gordon, R.T., Hines, J.R., Gordon, D., Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypotheses 5 (1979), 83–102.
69. [69] Wang, Y., Gu, H., Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. Adv Mater 27 (2015), 576–585.
70. [70] Terreno, E., Uggeri, F., Aime, S., Image guided therapy: the advent of theranostic agents. J Control Release 161 (2012), 328–337.
71. [71] Janib, S.M., Moses, A.S., Mackay, J.A., Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62 (2010), 1052–1063.
72. [72] MacDonald, T.D., Liu, T.W., Zheng, G., An MRI-sensitive, non-photobleachable porphysome photothermal agent. Angew Chem Int Ed Engl 53 (2014), 6956–6959.
73. [73] Na, H.B., Song, I.C., Hyeon, T., Inorganic nanoparticles for MRI contrast agents. Adv Mater 21 (2009), 2133–2148.
74. [74] Lee, N., Kim, H., Choi, S.H., et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc Natl Acad Sci USA 108 (2011), 2662–2667.
75. [75] Smith, C.E., Ernenwein, D., Shkumatov, A., et al. Hydrophilic packaging of iron oxide nanoclusters for highly sensitive imaging. Biomaterials 69 (2015), 184–190.
76. [76] Yu, J., Chu, X., Hou, Y., Stimuli-responsive cancer therapy based on nanoparticles. Chem Commun (Camb) 50 (2014), 11614–11630.
77. [77] Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12 (2013), 991–1003.
78. [78] Deelman, L.E., Decleves, A.E., Rychak, J.J., et al. Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev 62 (2010), 1369–1377.
79. [79] Weiyang, L., Xin, C., Chulhong, K., et al. Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasound. Nanoscale 3 (2011), 1724–1730.
80. [80] Moon, G.D., Choi, S.W., Cai, X., et al. A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. J Am Chem Soc 133 (2011), 4762–4765.
81. [81] Geers, B., Dewitte, H., De Smedt, S.C., et al. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J Control Release 164 (2012), 248–255.
82. [82] Liang, X., Gao, J., Jiang, L., et al. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. ACS Nano 9 (2015), 1280–1293.
83. [83] Pitt, W.G., Husseini, G.A., Staples, B.J., Ultrasonic drug delivery – a general review. Expert Opin Drug Deliv 1 (2004), 37–56.
84. [84] Schroeder, A., Honen, R., Turjeman, K., et al. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release 137 (2009), 63–68.
85. [85] Kooiman, K., Vos, H.J., Versluis, M., et al. Acoustic behavior of microbubbles and implications for drug delivery. Geophys Res Lett 28 (2001), 4283–4286.
86. [86] De Cock, I., Lajoinie, G., Versluis, M., et al. I. Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. Biomaterials 83 (2016), 294–307.
87. [87] Klibanov, A.L., Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 41 (2006), 354–362.
88. [88] Eunah, K., Hyun Su, M., Jaeyoung, L., et al. Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects. Angew Chem Int Ed Engl 49 (2010), 524–528.
89. [89] Lee, J.W., Jung, M.C., Park, H.D., et al. Synthesis and characterization of thermosensitive chitosan copolymer as a novel biomaterial. J Biomater Sci Polymer, Edn 15 (2004), 214–303.
90. [90] Lee, J., Min, H.S., You, D.G., et al. Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma. J Control Release 223 (2016), 197–206.
91. [91] Huynh, E., Leung, B.Y., Helfield, B.L., et al. In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol 10 (2015), 325–332.
92. [92] Li, W.P., Su, C.H., Chang, Y.C., et al. Ultrasound-induced reactive oxygen species mediated therapy and imaging using a Fenton reaction activable polymersome. ACS Nano 10 (2016), 2017–2027.